Pharmaceuticals Global On demand · 24-48h

Global Butterbur Herb Extract Market Strategic Research Report

Global Butterbur Herb Extract Market Strategic Research Repo…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Butterbur Herb Extract Market
$542025
5.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Liquid, Powder

By Application: Pharmaceutical, Dietary Supplement, Food, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Organic Herb, Martin Bauer Group, Shaanxi New Horizon Biotechnology, Xian Tianxingjian Natural Bio-products, Ciyuan Biology, Shaanxi Yongyuan Biotechnology, Shaanxi Sinuote Biotechnology, Changsha Hejian Biotechnology, Xian Jingmei Biotechnology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 99 pages
Market size 2025
$54
Million USD
Forecast CAGR
5.1%
2025-2032
Forecast 2032
$76.5
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Butterbur Herb Extract market size is predicted to grow from US$ 54.00 million in 2025 to US$ 76.45 million in 2032; it is expected to grow at a CAGR of 5.1% from 2026 to 2032.

In 2025, the global production of Butterbur Herb Extract is approximately 1640 tons, with an average selling price of about US$32/kg. The production capacity in 2025 is 1920 tons, with an average gross profit margin of approximately 25-35%. Butterbur Herb Extract is a plant extract derived from the dried whole herb of the butterbur plant (Petasites hybridus), a member of the Asteraceae family. Its main components include petasin, flavonoids, and volatile oils. It has potential applications in migraine prevention, anti-inflammatory effects, and antioxidant properties.

The upstream raw material for Butterbur Herb Extract is primarily the dried rhizome of the butterbur plant. Its core value and risks coexist: it contains the target active ingredient, petasin, but also naturally contains hepatotoxic pyrrolizidine alkaloids. Downstream applications are entirely based on safe detoxification and are strictly concentrated in the dietary supplement field. It is used as a professional-grade natural ingredient, supported by clinical research, for preventing migraines and managing seasonal allergic rhinitis. Its anti-inflammatory properties are also used in a few topical skincare products. The core challenge of the entire industry chain is to remove toxic substances while preserving and standardizing its therapeutic components.

The Butterbur Herb Extract market is showing steady growth, primarily driven by the global trend of upgrading health consumption and the expanding demand for plant-based ingredients. Its core active component, petasin, has received further clinical support for its value in alleviating allergies and inflammation, and is widely used in dietary supplements, functional foods, and high-end skincare products, particularly in the European, American, Japanese, and South Korean markets. The current market is dominated by a few companies that possess standardized cultivation and purification technologies, with product quality and ingredient standardization being key competitive factors. However, the market also faces challenges, including the impact of climate change on raw material supply stability, strict regulations on the safety of pyrrolizidine alkaloids in some regions, and the need for further consumer education. In the future, with the optimization of extraction processes to reduce the risk of pyrrolizidine alkaloids, the expansion of application scenarios to more functional products, and the gradual release of potential in the Asian market, the Butterbur Herb Extract market is expected to continue to grow, but requires collaborative efforts from all stakeholders in the supply chain regarding quality control and compliance.

This report presents a comprehensive overview of the global Butterbur Herb Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Liquid
  • Powder

Segment by Extract Ratio

  • 10:1
  • 20:1
  • 50:1
  • Other

Segment by Extraction Method

  • Water Extract
  • Alcohol Extract
  • Supercritical CO₂ Extract
  • Others

Segment by Application

  • Pharmaceutical
  • Dietary Supplement
  • Food
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Butterbur Herb Extract market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceutical, Dietary Supplement, Food evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Butterbur Herb Extract Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$54
2025
Forecast
$76.5
2032
CAGR
5.1%
2025–2032
Regions
5
global
Key companies
Organic HerbMartin Bauer GroupShaanxi New Horizon BiotechnologyXian Tianxingjian Natural Bio-productsCiyuan BiologyShaanxi Yongyuan BiotechnologyShaanxi Sinuote BiotechnologyChangsha Hejian Biotechnology
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
LiquidPowder
By Application
PharmaceuticalDietary SupplementFoodOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Liquid
  • 3.1.3 Powder
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceutical
  • 4.1.3 Dietary Supplement
  • 4.1.4 Food
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Organic Herb
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Martin Bauer Group
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Shaanxi New Horizon Biotechnology
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Xian Tianxingjian Natural Bio-products
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Ciyuan Biology
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Shaanxi Yongyuan Biotechnology
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Shaanxi Sinuote Biotechnology
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Changsha Hejian Biotechnology
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Xian Jingmei Biotechnology
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Butterbur Herb Extract market?
The global Butterbur Herb Extract market is estimated at US$ 54 million in 2025 (base year) and is projected to reach US$ 76.45 million by 2032.
How fast is the Butterbur Herb Extract market expected to grow?
The market is expected to grow at a CAGR of 5.1% from 2026 to 2032, expanding from US$ 54 million in 2025 to US$ 76.45 million in 2032, roughly 1.4 times its base-year value.
What does the Butterbur Herb Extract market cover?
In 2025, the global production of Butterbur Herb Extract is approximately 1640 tons, with an average selling price of about US$32/kg. The production capacity in 2025 is 1920 tons, with an average gross profit margin of approximately 25-35%. Butterbur Herb Extract is a plant extract derived from the dried whole herb of the butterbur plant (Petasites hybridus), a member of the Asteraceae family.
How is the Butterbur Herb Extract market segmented by type?
By type, the market is segmented into Liquid and Powder.
What are the key applications of Butterbur Herb Extract?
Key applications covered include Pharmaceutical, Dietary Supplement, Food and Others.
Which companies are profiled in the Butterbur Herb Extract market report?
Key players profiled include Organic Herb, Martin Bauer Group, Shaanxi New Horizon Biotechnology, Xian Tianxingjian Natural Bio-products, Ciyuan Biology, Shaanxi Yongyuan Biotechnology, Shaanxi Sinuote Biotechnology and Changsha Hejian Biotechnology, among 9 companies covered in total.
What geographies does the Butterbur Herb Extract market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Butterbur Herb Extract?
It is used as a professional-grade natural ingredient, supported by clinical research, for preventing migraines and managing seasonal allergic rhinitis.
What are the main risks and barriers in the Butterbur Herb Extract market?
Its main components include petasin, flavonoids, and volatile oils.
Who should buy the Butterbur Herb Extract market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical, Dietary Supplement and Food, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Butterbur Herb Extract market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.